Homo sapiens Protein: GNAS | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||||||||
InnateDB Protein | IDBP-82833.7 | ||||||||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||||||||
Gene Symbol | GNAS | ||||||||||||||||||||||||||||
Protein Name | GNAS complex locus | ||||||||||||||||||||||||||||
Synonyms | AHO; C20orf45; GNAS1; GPSA; GSA; GSP; NESP; PHP1A; PHP1B; PHP1C; POH; | ||||||||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||||||||
Ensembl Protein | ENSP00000360143 | ||||||||||||||||||||||||||||
InnateDB Gene | IDBG-82827 (GNAS) | ||||||||||||||||||||||||||||
Protein Structure | |||||||||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||||||||
Function | Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. The G(s) protein is involved in hormonal regulation of adenylate cyclase: it activates the cyclase in response to beta-adrenergic stimuli. XLas isoforms interact with the same set of receptors as Gnas isoforms (By similarity). {ECO:0000250}. | ||||||||||||||||||||||||||||
Subcellular Localization | Cell membrane {ECO:0000250UniProtKB:Q63803}; Peripheral membrane protein {ECO:0000250UniProtKB:Q63803}. | ||||||||||||||||||||||||||||
Disease Associations | GNAS hyperfunction (GNASHYP) [MIM:139320]: This condition is characterized by increased trauma-related bleeding tendency, prolonged bleeding time, brachydactyly and mental retardation. Both the XLas isoforms and the ALEX protein are mutated which strongly reduces the interaction between them and this may allow unimpeded activation of the XLas isoforms. {ECO:0000269PubMed:11583302, ECO:0000269PubMed:12719376}. Note=The disease is caused by mutations affecting the gene represented in this entry.ACTH-independent macronodular adrenal hyperplasia (AIMAH) [MIM:219080]: A rare adrenal defect characterized by multiple, bilateral, non-pigmented, benign, adrenocortical nodules. It results in excessive production of cortisol leading to ACTH- independent Cushing syndrome. Clinical manifestations of Cushing syndrome include facial and truncal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes. {ECO:0000269PubMed:12727968}. Note=The disease is caused by mutations affecting the gene represented in this entry.Pseudohypoparathyroidism 1B (PHP1B) [MIM:603233]: A disorder characterized by end-organ resistance to parathyroid hormone, hypocalcemia and hyperphosphatemia. Patients affected with PHP1B lack developmental defects characteristic of Albright hereditary osteodystrophy, and typically show no other endocrine abnormalities besides resistance to PTH. {ECO:0000269PubMed:11029463, ECO:0000269PubMed:11067869, ECO:0000269PubMed:11294659, ECO:0000269PubMed:12858292, ECO:0000269PubMed:14561710, ECO:0000269PubMed:15592469, ECO:0000269PubMed:15800843}. Note=The disease is caused by mutations affecting the gene represented in this entry. Most affected individuals have defects in methylation of the gene. In some cases microdeletions involving the STX16 appear to cause loss of methylation at exon A/B of GNAS, resulting in PHP1B. Paternal uniparental isodisomy have also been observed.Pseudohypoparathyroidism 1C (PHP1C) [MIM:612462]: A disorder characterized by end-organ resistance to parathyroid hormone, hypocalcemia and hyperphosphatemia. It is commonly associated with Albright hereditary osteodystrophy whose features are short stature, obesity, round facies, short metacarpals and ectopic calcification. {ECO:0000269PubMed:11788646}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||||||||||||
Tissue Specificity | |||||||||||||||||||||||||||||
Comments | |||||||||||||||||||||||||||||
Interactions | |||||||||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 52 experimentally validated interaction(s) in this database.
They are also associated with 2 interaction(s) predicted by orthology.
|
||||||||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||||||||
InterPro |
IPR000367
G-protein alpha subunit, group S IPR001019 Guanine nucleotide binding protein (G-protein), alpha subunit IPR006689 Small GTPase superfamily, ARF/SAR type IPR011025 G protein alpha subunit, helical insertion IPR027417 P-loop containing nucleoside triphosphate hydrolase |
||||||||||||||||||||||||||||
PFAM |
PF00503
PF00025 |
||||||||||||||||||||||||||||
PRINTS |
PR00443
PR00318 PR00328 |
||||||||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||||||||
SMART |
SM00275
|
||||||||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||||||||
Modification | |||||||||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||||||||
SwissProt | Q5JWF2 | ||||||||||||||||||||||||||||
PhosphoSite | PhosphoSite-Q5JWF2 | ||||||||||||||||||||||||||||
TrEMBL | |||||||||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||||||||
Entrez Gene | 2778 | ||||||||||||||||||||||||||||
UniGene | Hs.694849 | ||||||||||||||||||||||||||||
RefSeq | XP_006723845 | ||||||||||||||||||||||||||||
HUGO | HGNC:4392 | ||||||||||||||||||||||||||||
OMIM | 139320 | ||||||||||||||||||||||||||||
CCDS | |||||||||||||||||||||||||||||
HPRD | 00761 | ||||||||||||||||||||||||||||
IMGT | |||||||||||||||||||||||||||||
EMBL | AJ224867 AJ224868 AJ251760 AL109840 AL121917 AL132655 AY898804 CH471077 | ||||||||||||||||||||||||||||
GenPept | AAX51890 CAA12164 CAA12165 CAB83215 CAI42566 CAI42567 CAI42932 CAI42933 CAI43073 CAI43074 CAM28315 EAW75462 EAW75469 | ||||||||||||||||||||||||||||